Relationship of urinary cGMP excretion with aging and menopausal status in a general population

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 4, 2009, Pages 457-462

  Cui, Renzhe ^a   Iso, Hiroyasu ^a   Yamagishi, Kazumasa ^b   Ohira, Tetsuya ^a,d   Tanigawa, Takeshi ^c   Kitamura, Akihiko ^d   Kiyama, Masahiko ^d   Imano, Hironori ^a,d   Konishi, Masamitsu ^d   Shimamoto, Takashi ^d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

cGMP; Cross sectional studies; Epidemiology; Postmenopausal

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; CYCLIC GMP;

ADULT; AGE; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; HUMAN; HYPERTENSION; JAPANESE; MALE; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTOR; URINARY EXCRETION; VASODILATATION;

EID: 73249137948     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.No083     Document Type: Article

References (27)

1. Booz GW: Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system. Hypertension, 2005; 45:341-346
2. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med, 1993; 329:2002-2012
3. Wright SP, Prickett TC, Doughty RN, Frampton C, Gamble GD, Yandle TG, et al: Amino-terminal pro-C-type natriuretic peptide in heart failure. Hypertension, 2004; 43:94-100
4. Szilvássy Z, Csont T, Páli T, Droy-Lefaix MT, Ferdinandy P: Nitric oxide, peroxynitrite and cGMP in atherosclerosis-induced hypertension in rabbits: beneficial effects of cicletanine. J Vasc Res, 2001; 38:39-4
5. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich JC: Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation, 1997; 95:2068-2074
6. Cui R, Iso H, Pi J, Kumagai Y, Yamagishi K, Tanigawa T, Shimamoto T: Metabolic syndrome and urinary cGMP excretion in a general population. Atherosclerosis, 2007; 190:423-428
7. Cui R, Iso H, Pi J, Kumagai Y, Yamagishi K, Tanigawa T, Shimamoto T: Relationship between urinary cGMP excretion and serum total cholesterol levels in a general population. Atherosclerosis, 2005; 179:379-386
8. Gordon T, Kannel WB, Hjortland MC, McNamara PM: Menopause and coronary heart disease. The Framingham Study. Ann Intern Med, 1978; 89:157-161
9. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH: Menopause and the risk of coronary heart disease in women. N Engl J Med, 1987; 316:1105-1110
10. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, Sudano I, Solvetti A: Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation, 1995; 91:1981-1987
11. Kirma C, Akcakoyun M, Esen AM, Barutcu I, Karakaya O, Saglam M, Kagin R, Turkmen M, Boztosur B, Izgi A, Senmez K: Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease. Circ J, 2007; 71:698-702
12. Higashi Y, Oshima T, Ozono R, Matsuura H, Kajiyama G: Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension, 1997; 30:252-258
13. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, Pinto S, Salvetti A: Menopause is associated with endothelial dysfunction in women. Hypertension, 1996; 28:576-582
14. Herrington DM, Espeland MA, Crouse JR 3rd, Robertson J, Riley WA, McBurnie MA, Burke GL: Estrogen replacement and brachial artery flow-mediated vasodilation in older women. Arterioscler Thromb Vasc Biol, 2001; 21:1955-1961
15. Yoshihisa A, Iwai-Takano M, Yaoita H, Watanabe T, Maruyama Y: Difference in early effects of statin therapy on coronary and forearm flow reserve in postmenopausal hypercholesterolemic women. Circ J, 2007; 71:954-961
16. Kirkendall WM, Feinleib M, Freis ED, Mark AL: Recommendations for human blood pressure determination by sphygmomanometers. Subcommittee of the AHA Postgraduate Education Committee. Circulation, 1980; 62:1146A-1155A
17. Shimamoto T, Komachi Y, Inada H, Doi M, Iso H, Sato S, Kitamura A, Iida M, Konishi M, Nakanishi N: Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation, 1989; 79:503-515
18. Shimamoto T, Iso H, Tanigawa T, Sankai T, Ohira T, Okawa Y, et al: Stroke, ischemic heart disease and their risk factors in Kyowa town, Ibaraki, Japan. Cardioangiology, 2000; 48:127-133 (in Japanese)
19. Nakamura M, Sato S, Shimamoto T: Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. J Atheroscler Thromb, 2003; 10:145-153
20. Ghasemi A, Zahedi Asl S, Mehrabi Y, Saadat N, Azizi F: Serum nitric oxide metabolite levels in a general healthy population: relation to sex and age. Life Sci, 2008; 83:326-331
21. Cernadas MR, Sánchez de Miguel L, García-Durán M, González-Fernández F, Millás I, Montón M, Radrigo J, Rico L, Fernández P, de Frutos T, Rodríguez-Feo JA, Guerra J, Caramelo C, Casada S, López-Farré: Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res, 1998; 83:279-286
22. Chou TC, Yen MH, Li CY, Ding YA: Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension, 1998; 31:643-648
23. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J, 1992; 6:3051-3064 24) Kato J, Kitamura K, Uemura T, Kuwasako K, Kita T, Kangawa K, Eto T: Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res, 2002; 25:887-892
24. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr: Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol, 2002; 40:976-982
25. Kaneki H, Kurokawa M, Ide H: The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging. J Cell Biochem, 2008; 103:753-764
26. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks F: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med, 1991; 325:1196-1204
27. Kalantaridou SN, Naka KK, Papanikolaou E, Kazakos N, Kravariti M, Calis KA, Paraskevaidis EA, Sideris DA, Tsatsoulis A, Chrousos GP, Michalis LA: Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab, 2004; 89:3907-3913